Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.
暂无分享，去创建一个
J. Hauber | A. Nordheim | C. Bokemeyer | T. Brümmendorf | S. Balabanov | L. Kanz | M. Copland | T. Holyoake | I. Hauber | Gerold Schwarz | U. Hartmann | W. Kammer | P. Ziegler | T. Wilhelm | A. Gontarewicz | U. Brassat | M. Priemer